MRI-Based Radiomics Approach Predicts Tumor Recurrence in ER + /HER2 − Early Breast Cancer Patients.

Oncotype Dx Recurrence Score (RS) has been validated in patients with ER + /HER2 − invasive breast carcinoma to estimate patient risk of recurrence and guide the use of adjuvant chemotherapy. We investigated the role of MRI-based radiomics features extracted from the tumor and the peritumoral tissue...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Digital Imaging Vol. 36; no. 3; pp. 1071 - 1081
Autores principales: Chiacchiaretta, Piero, Mastrodicasa, Domenico, Chiarelli, Antonio Maria, Luberti, Riccardo, Croce, Pierpaolo, Sguera, Mario, Torrione, Concetta, Marinelli, Camilla, Marchetti, Chiara, Domenico, Angelucci, Cocco, Giulio, Di Credico, Angela, Russo, Alessandro, D'Eramo, Claudia, Corvino, Antonio, Colasurdo, Marco, Sensi, Stefano L., Muzi, Marzia, Caulo, Massimo, Delli Pizzi, Andrea
Formato: diagnostic images research tables/charts Journal Article
Publicado: Springer Nature Jun2023
Acceso en línea:Ver este registro en EBSCOhost